Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-841-3 | CAS number: 7758-88-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 7 January 1987 - 22 January 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to GLP in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- see below
- Principles of method if other than guideline:
- The acclimation period prior to the administration of the test material is not specified; the protocol states that it was a minimum of 48 hours. This deviation was not considered to have had an impact on the outcome of the study.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Cerium trifluoride
- EC Number:
- 231-841-3
- EC Name:
- Cerium trifluoride
- Cas Number:
- 7758-88-5
- Molecular formula:
- CeF3
- IUPAC Name:
- cerium trifluoride
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Appearance: pink powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Ico rats: OFA.SD (IOPS Caw)
- Age at study initiation: 5 - 7 weeks
- Weight at study initiation (prior to fasting): 182 - 193 g (males); 170 - 185 g (females)
- Fasting period before study: yes (15 - 20 hours)
- Housing: 5 animals in stainless steel mesh cages (343 x 250 x 140 mm)
- Food consumption: ad libitum with the exception of the pre-dose fast and 3 - 4 hours following the administration of the test material.
- Water consumption: ad libitum
- Acclimation period: minimum of 48 hours
ENVIRONMENTAL CONDITIONS:
- Temperature: 22 ± 3 °C
- Humidity: 30 - 70 %
- Photoperiod: 12 hours light-dark cycle was maintained (photoperiod 0730 to 1930).
IN-LIFE DATES: From: 7 January 1987 To: 22 January 1987
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 10 % aqueous dispersion of gum arabic
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 mL/kg
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
Preparation of the suspension: the powdered test material was put in a 20 % (w/v) suspension made immediately prior to administration in a 10 % (w/v) aqueous dispersion of gum arabic. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 animals per sex per dose.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
> behaviour and mortality: 15 minutes after administration of the test material, then after 1, 2 and 4 hours. Daily observations were then made for the 14 day duration of the observation period.
> weighing: one day before treatment, and on days 1, 8 and 15 after treatment
- Necropsy of survivors performed: yes
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed in rats dosed with 2000 mg/kg bw.
- Clinical signs:
- other: No clinical signs were observed.
- Gross pathology:
- No gross abnormalities were observed at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD0 (males and females) was ≥ 2000 mg/kg bw and therefore the test material is not classified for acute oral toxicity based on the results of this study in accordance with EU criteria.
- Executive summary:
An acute oral toxicity limit test was conducted to assess the test material in accordance with the standardised guideline OECD 401.
Groups of fasted, 5 - 7 week old Sprague-Dawley rats (5 per sex) were given a single oral dose of the test material administered as a 20 % suspension (w/v) in an aqueous dispersion of 10 % (w/v) of gum arabic at a dose of 2000 mg/kg bw and observed for 14 days.
No mortality and no clinical signs were observed during the study. No gross abnormalities were observed at necropsy.
The oral LD0 (males and females) was ≥ 2000 mg/kg bw and therefore the test material is not classified for acute oral toxicity based on the results of this study in accordance with EU criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.